Anthony K Park

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2026
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory.

Annie Yang, Zhifang Zhang, Anthony K Park

|Aug 11, 2025
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors.

Anthony K Park, Isabel Monroy, Yuwei Ren

|Dec 09, 2023
Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies.

Courtney Chen, Audrey Jung, Annie Yang

|Sep 28, 2023
Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients.

Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya

|Apr 05, 2023
Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.

Annie Yang, Zhifang Zhang, Shyambabu Chaurasiya

|Sep 04, 2020
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.

Anthony K Park, Yuman Fong, Sang-In Kim

Pageof 1

Frequent Collaborators

3 joint publications

Saul Priceman

3 joint publications

Shyambabu Chaurasiya

2 joint publications

Yanghee Woo

1 joint publications

Yuman Fong